‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV
Our findings confirm the long-term effectiveness and tolerability of dolutegravir plus lamivudine in virologically suppressed PWH.
Authors
- Arturo Ciccullo (ORCID: https://orcid.org/0000-0001-5941-883X)
- Alberto Borghetti (ORCID: https://orcid.org/0000-0002-5011-3324)
- Damiano Farinacci (ORCID: https://orcid.org/0000-0001-9106-7742)
- Francesca Lombardi (ORCID: https://orcid.org/0000-0001-5757-8346)
- Pierluigi Francesco Salvo (ORCID: https://orcid.org/0000-0001-7559-7364)
- Gianmaria Baldin (ORCID: https://orcid.org/0000-0003-4623-9976)
- Valentina Iannone (ORCID: https://orcid.org/0000-0002-0751-8836)
- Francesco Lamanna (ORCID: https://orcid.org/0009-0005-1956-9277)
- Andrea Carbone
- Carlo Torti
- Rosa Anna Passerotto
- Simona Di Giambenedetto
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- San Salvatore Hospital (IT)
- University of the Sacred Heart (JP)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- AIDS
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1097/qad.0000000000004153
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00